Mcf Advisors LLC Astrazeneca PLC Transaction History

Mcf Advisors LLC

$1.55 Billion
Q3 2025

A detailed history of Mcf Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mcf Advisors LLC holds 5 shares of AZN stock, worth $447. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$447

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	BUY	$68.72 - $82.11 $343 - $410	5 New	5 $0
Q4 2024 Jan 17, 2025	BUY	$63.2 - $79.58 $821 - $1,034	13 New	13 $0
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $17,778 - $21,342	300 New	300 $20,000

Others Institutions Holding AZN

# of Institutions

1,505

Shares Held

501M

Call Options Held

5.59M

Put Options Held

3.18M

Price T Rowe Associates Inc Baltimore, MD

49.1M
Shares

$4.39 Billion
0.4% of portfolio
Primecap Management CO Pasadena, CA

39.9M
Shares

$3.56 Billion
2.42% of portfolio
Bank Of America Corp Charlotte, NC

32.6M
Shares

$2.92 Billion
0.18% of portfolio
Wellington Management Group LLP Boston, MA

32.3M
Shares

$2.89 Billion
0.45% of portfolio
Capital International Investors Los Angeles, CA

25.1M
Shares

$2.24 Billion
0.33% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account